Pete Corish
Chief Executive Officer chez Rivela Diagnostics Ltd.
Profil
Pete Corish is BroadOak’s VP Business Development in Europe, expanding the recognition of, and access to, BroadOak’s expertise, capabilities and services to European Life Science companies and investors.
With 20 years of experience in core clinical laboratory, Point-of-Care immunoassay, and molecular diagnostics markets, Pete has focused on commercialising R&D and third-party innovative technologies in a number of Life Science and IVD businesses in the UK and US, including Alere, Oxford Gene Technology, Arrow Therapeutics, and Oxonica Healthcare plc.
This has included applications for novel nanoparticle biolabels, DNA microarray analysis, genomic technologies for drug development, and new platforms for rapid, in-field diagnostics with digital connectivity.
As the former Chief Technology Officer of BBI Solutions, a leading independent provider of diagnostic reagents and services, Pete was responsible for M&A, Commercial Strategic Partnerships and technology Licensing/R&D, building out their product and innovative technology portfolios.
Pete gained his bachelor and doctorate degrees in Molecular Genetics from the Universities of Nottingham and Cambridge (UK) respectively, and is based in Cardiff, the capital of Wales, and only two hours from the principal European Life Science hubs.
Postes actifs de Pete Corish
| Sociétés | Poste | Début |
|---|---|---|
BroadOak Capital Partners LLC
 BroadOak Capital Partners LLC Investment ManagersFinance BroadOak Capital Partners LLC (BroadOak Capital Partners) is a private equity firm founded in 2006 by Bill Snider and Lars Hanan. The firm is headquartered in Maryland. | Private Equity Investor | 01/02/2023 |
| Rivela Diagnostics Ltd. | Chief Executive Officer | 01/04/2022 |
Anciens postes connus de Pete Corish
| Sociétés | Poste | Fin |
|---|---|---|
BBI Diagnostics Group Ltd.
 BBI Diagnostics Group Ltd. Medical SpecialtiesHealth Technology BBI Diagnostics Group Ltd. develops and manufactures raw materials and finished test platforms for the in-vitro diagnostics market. The firm’s products include cell culture reagents, conjugates, depleted serum, disease state plasma, enzymes, finished kits, gold nanoparticles, monoclonal antibodies, normal serums, patient samples, polyclonal antibodies, recombinant antibodies, silver nanoparticles, biothreat and explosives antibodies. It’s services include custom conjugation, lateral flow assay development, 3DNA pushing assay sensitivity to the limit, test optimisation, atomo rapid platform and the novarum reader. The company was founded by John Chandler in 1986 and is headquartered in Cardiff, the United Kingdom. | Corporate Officer/Principal | 01/08/2021 |
British Biocell International Ltd.
 British Biocell International Ltd. Pharmaceuticals: MajorHealth Technology Part of BBI Diagnostics Group Ltd., British Biocell International Ltd. is a private group led by Julian Baines. The private company is based in Cardiff, UK. British Biocell International was acquired by BBI Diagnostics Group Ltd. on January 31, 2001. | Chief Executive Officer | 01/12/2009 |
Arrow Therapeutics Ltd.
 Arrow Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arrow Therapeutics Ltd. operates as a pharmaceutical company that focuses on research and development of novel antiviral drugs. Its products include novel antibacterial, antiviral, antifungal and preclinical compounds. The company was founded in 1998 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | 01/12/2003 |
BBI Solutions OEM Ltd.
 BBI Solutions OEM Ltd. Chemicals: SpecialtyProcess Industries BBI Solutions OEM Ltd. develops and manufactures raw materials and finished test platforms for the in-vitro diagnostics market. It offers gold reagents, antibodies, antigens, biobank, cell culture, reagents, and enzymes. The firm services include lateral flow assay development, lateral flow test manufacture, and case studies. The company was founded in John Chandler in 1986 and is headquartered in Cardiff, the United Kingdom. | Chief Tech/Sci/R&D Officer | - |
Formation de Pete Corish
| University of Oxford | Graduate Degree |
| University of Cambridge | Doctorate Degree |
| University of Leicester | Graduate Degree |
| University of Nottingham Malaysia | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
BBI Diagnostics Group Ltd.
BBI Diagnostics Group Ltd. Medical SpecialtiesHealth Technology BBI Diagnostics Group Ltd. develops and manufactures raw materials and finished test platforms for the in-vitro diagnostics market. The firm’s products include cell culture reagents, conjugates, depleted serum, disease state plasma, enzymes, finished kits, gold nanoparticles, monoclonal antibodies, normal serums, patient samples, polyclonal antibodies, recombinant antibodies, silver nanoparticles, biothreat and explosives antibodies. It’s services include custom conjugation, lateral flow assay development, 3DNA pushing assay sensitivity to the limit, test optimisation, atomo rapid platform and the novarum reader. The company was founded by John Chandler in 1986 and is headquartered in Cardiff, the United Kingdom. | Health Technology |
Arrow Therapeutics Ltd.
Arrow Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arrow Therapeutics Ltd. operates as a pharmaceutical company that focuses on research and development of novel antiviral drugs. Its products include novel antibacterial, antiviral, antifungal and preclinical compounds. The company was founded in 1998 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
British Biocell International Ltd.
British Biocell International Ltd. Pharmaceuticals: MajorHealth Technology Part of BBI Diagnostics Group Ltd., British Biocell International Ltd. is a private group led by Julian Baines. The private company is based in Cardiff, UK. British Biocell International was acquired by BBI Diagnostics Group Ltd. on January 31, 2001. | Health Technology |
BroadOak Capital Partners LLC
BroadOak Capital Partners LLC Investment ManagersFinance BroadOak Capital Partners LLC (BroadOak Capital Partners) is a private equity firm founded in 2006 by Bill Snider and Lars Hanan. The firm is headquartered in Maryland. | Finance |
BBI Solutions OEM Ltd.
BBI Solutions OEM Ltd. Chemicals: SpecialtyProcess Industries BBI Solutions OEM Ltd. develops and manufactures raw materials and finished test platforms for the in-vitro diagnostics market. It offers gold reagents, antibodies, antigens, biobank, cell culture, reagents, and enzymes. The firm services include lateral flow assay development, lateral flow test manufacture, and case studies. The company was founded in John Chandler in 1986 and is headquartered in Cardiff, the United Kingdom. | Process Industries |
| Rivela Diagnostics Ltd. |
